Correlation Between Neurocrine Biosciences and 191216CX6

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and 191216CX6 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and 191216CX6 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and COCA COLA CO, you can compare the effects of market volatilities on Neurocrine Biosciences and 191216CX6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of 191216CX6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and 191216CX6.

Diversification Opportunities for Neurocrine Biosciences and 191216CX6

0.12

Correlation Coefficient

Neurocrine Biosciences  191216CX6

Average diversification

The 3 months correlation between Neurocrine and 191216CX6 is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and COCA COLA CO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COCA A CO and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with 191216CX6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COCA A CO has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and 191216CX6 go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and 191216CX6

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 1.29 times less return on investment than 191216CX6. But when comparing it to its historical volatility, Neurocrine Biosciences is 2.8 times less risky than 191216CX6. It trades about 0.33 of its potential returns per unit of risk. COCA COLA CO is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  6,397  in COCA COLA CO on September 29, 2024 and sell it today you would earn a total of  829.00  from holding COCA COLA CO or generate 12.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	90.91%
Values	Daily Returns

Neurocrine Biosciences  vs.  COCA COLA CO

Neurocrine Biosciences

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

COCA A CO

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in COCA COLA CO are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 191216CX6 may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Neurocrine Biosciences and 191216CX6

The main advantage of trading using opposite Neurocrine Biosciences and 191216CX6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, 191216CX6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 191216CX6 will offset losses from the drop in 191216CX6's long position.

The idea behind Neurocrine Biosciences and COCA COLA CO pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.